Pfizer policy to broaden access to clinical trials

Pfizer Inc. has announced a plan to broaden access to company-sponsored clinical trials.

The new policy will allow researchers new access to trial results at, calls for Pfizer to publish synopses of clinical trial reports at, promises the company will make lay-language summaries of results available and calls for use of a new technology that will allow trial participants to access their own data.

Pfizer said the policy is in keeping with the "Principles for Responsible Data Sharing" report issued earlier this year by the Pharmaceutical Research and Manufacturers of America and the European Federation of Pharmaceutical Industries and Associations.


Loading comments...
Hide Comments